270 related articles for article (PubMed ID: 1900240)
21. Enhancement of macrophage IL-1 production by Leishmania major infection in vitro and its inhibition by IFN-gamma.
Cillari E; Dieli M; Maltese E; Milano S; Salerno A; Liew FY
J Immunol; 1989 Sep; 143(6):2001-5. PubMed ID: 2506273
[TBL] [Abstract][Full Text] [Related]
22. Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism.
Green SJ; Meltzer MS; Hibbs JB; Nacy CA
J Immunol; 1990 Jan; 144(1):278-83. PubMed ID: 2104889
[TBL] [Abstract][Full Text] [Related]
23. Differential susceptibility of activated macrophage cytotoxic effector reactions to the suppressive effects of transforming growth factor-beta 1.
Nelson BJ; Ralph P; Green SJ; Nacy CA
J Immunol; 1991 Mar; 146(6):1849-57. PubMed ID: 1900875
[TBL] [Abstract][Full Text] [Related]
24. Changes in the precursor frequencies of IL-4 and IFN-gamma secreting CD4+ cells correlate with resolution of lesions in murine cutaneous leishmaniasis.
Morris L; Troutt AB; Handman E; Kelso A
J Immunol; 1992 Oct; 149(8):2715-21. PubMed ID: 1357029
[TBL] [Abstract][Full Text] [Related]
25. A new function of the Fas-FasL pathway in macrophage activation.
Chakour R; Allenbach C; Desgranges F; Charmoy M; Mauel J; Garcia I; Launois P; Louis J; Tacchini-Cottier F
J Leukoc Biol; 2009 Jul; 86(1):81-90. PubMed ID: 19380712
[TBL] [Abstract][Full Text] [Related]
26. Parasite accessory cell interactions in murine leishmaniasis. I. Evasion and stimulus-dependent suppression of the macrophage interleukin 1 response by Leishmania donovani.
Reiner NE
J Immunol; 1987 Mar; 138(6):1919-25. PubMed ID: 3493291
[TBL] [Abstract][Full Text] [Related]
27. Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages.
Prina E; Lang T; Glaichenhaus N; Antoine JC
J Immunol; 1996 Jun; 156(11):4318-27. PubMed ID: 8666803
[TBL] [Abstract][Full Text] [Related]
28. Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine.
Liew FY; Millott S; Parkinson C; Palmer RM; Moncada S
J Immunol; 1990 Jun; 144(12):4794-7. PubMed ID: 2351828
[TBL] [Abstract][Full Text] [Related]
29. Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice.
Heinzel FP; Rerko RM; Ahmed F; Pearlman E
J Immunol; 1995 Jul; 155(2):730-9. PubMed ID: 7608551
[TBL] [Abstract][Full Text] [Related]
30. Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex.
Bermudez LE; Young LS
J Immunol; 1988 May; 140(9):3006-13. PubMed ID: 2834450
[TBL] [Abstract][Full Text] [Related]
31. Transfected Leishmania expressing biologically active IFN-gamma.
Tobin JF; Reiner SL; Hatam F; Zheng S; Leptak CL; Wirth DF; Locksley RM
J Immunol; 1993 Jun; 150(11):5059-69. PubMed ID: 8098724
[TBL] [Abstract][Full Text] [Related]
32. Leishmania sp: comparative study with Toxoplasma gondii and Trypanosoma cruzi in their ability to initialize IL-12 and IFN-gamma synthesis.
Oliveira MA; Santiago HC; Lisboa CR; Ceravollo IP; Trinchieri G; Gazzinelli RT; Vieira LQ
Exp Parasitol; 2000 Jun; 95(2):96-105. PubMed ID: 10910710
[TBL] [Abstract][Full Text] [Related]
33. Studies on intracellular killing of Leishmania major and lysis of host macrophages by immune lymphoid cells in vitro.
Pham TV; Mauël J
Parasite Immunol; 1987 Nov; 9(6):721-36. PubMed ID: 2448731
[TBL] [Abstract][Full Text] [Related]
34. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.
Sadick MD; Heinzel FP; Shigekane VM; Fisher WL; Locksley RM
J Immunol; 1987 Aug; 139(4):1303-9. PubMed ID: 3112230
[TBL] [Abstract][Full Text] [Related]
35. In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections.
Reed SG
J Immunol; 1988 Jun; 140(12):4342-7. PubMed ID: 3131431
[TBL] [Abstract][Full Text] [Related]
36. Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism.
Muñoz-Fernández MA; Fernández MA; Fresno M
Eur J Immunol; 1992 Feb; 22(2):301-7. PubMed ID: 1537373
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-15, as interferon-gamma, induces the killing of Leishmania infantum in phorbol-myristate-acetate-activated macrophages increasing interleukin-12.
D'Agostino P; Milano S; Arcoleo F; Di Bella G; La Rosa M; Ferlazzo V; Caruso R; Chifari N; Vitale G; Mansueto S; Cillari E
Scand J Immunol; 2004 Dec; 60(6):609-14. PubMed ID: 15584972
[TBL] [Abstract][Full Text] [Related]
38. Leishmania major-parasitized macrophages augment Th2-type T cell activation.
Chakkalath HR; Titus RG
J Immunol; 1994 Nov; 153(10):4378-87. PubMed ID: 7963516
[TBL] [Abstract][Full Text] [Related]
39. Effect of lipopolysaccharide on intracellular killing of Leishmania enriettii and correlation with macrophage oxidative metabolism.
Mauël J; Buchmüller-Rouiller Y
Eur J Immunol; 1987 Feb; 17(2):203-8. PubMed ID: 3030768
[TBL] [Abstract][Full Text] [Related]
40. IL-4 induces a Th2 response in Leishmania major-infected mice.
Chatelain R; Varkila K; Coffman RL
J Immunol; 1992 Feb; 148(4):1182-7. PubMed ID: 1531351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
